This innovation responds to an urgent medical need for severe respiratory distress care system in premature infants, new‐born infants, children and adults that cannot be treated by conventional gaseous ventilation. Indeed, despite recent progress in optimizing conventional mechanical ventilation, mortality due to acute respiratory distress syndrome remains high. On average, 20% of newborns with respiratory distress syndrome die. Development of the Inolivent device in order to make it available in intensive‐care unit is therefore essential. TECHNOLOGY
Medical device used to perform fluid total ventilations, i.e. to ventilate patients with a biologically inert liquid vector that is appropriate to gaseous exchanges.
The device purpose is to provide a simple, efficient, safe and reliable use.
Philippe Micheau is a Professor at the Department of Mechanical Engineering of the Université de Sherbrooke. Hervé Waiti is a Professor of neonatology at the Department of Pediatrics of the Université de Sherbrooke.由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。
acute
infants
ventilation
severe
distress
device
respiratory
gaseous
sherbrooke
inolivent